Literature DB >> 6386880

Enzyme-linked immunosorbent assay for the diagnosis of cerebral cysticercosis.

I N Mohammad, D C Heiner, B L Miller, M A Goldberg, I G Kagan.   

Abstract

Central nervous system cysticercosis is common in countries where Taenia solium occurs in pigs and the level of hygiene and sanitation is low. The clinical presentation may include epileptic seizures, focal neurological deficits, hydrocephalus, or aseptic meningitis. The disease is frequently seen in California residents of Hispanic origin. It sometimes occurs in whites from homes that employ Hispanic cooks. Diagnosis is often difficult. Computerized tomography scan and brain biopsy are the most reliable diagnostic procedures, but each has its limitations. We have found that a radioimmunoassay improves our diagnostic capability, and more recently we have adapted this to an enzyme-linked immunosorbent assay that is equally sensitive and specific and, in addition, obviates the need for radioactive materials. Details of the enzyme-linked immunosorbent assay procedure and its application to the diagnosis of central nervous system cysticercosis form the basis of this report.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386880      PMCID: PMC271429          DOI: 10.1128/jcm.20.4.775-779.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  [Seroepidemiologic study of human cysticerosis in the predominantly indigenous rural Indian population of the State of Chiapas].

Authors:  A Flisser; I Bulnes; M L Diaz; R Luna; E Woodhouse; F Beltran; I Martinez; C Larralde
Journal:  Arch Invest Med (Mex)       Date:  1976

2.  Comparative evaluation of indirect haemagglutination and complement fixation tests in serodiagnosis of cysticercosis.

Authors:  R C Mahajan; J S Chopra; N L Chitkara
Journal:  Indian J Med Res       Date:  1975-01       Impact factor: 2.375

3.  Serodiagnosis of human cysticercosis by microplate enzyme-linked immunospecific assay (ELISA).

Authors:  P V Arambulo; K W Walls; S Bullock; I G Kagan
Journal:  Acta Trop       Date:  1978-03       Impact factor: 3.112

4.  Current prevalence and distribution of hydatidosis with special reference to the Americas.

Authors:  J F Williams; H López Adaros; A Trejos
Journal:  Am J Trop Med Hyg       Date:  1971-03       Impact factor: 2.345

5.  Neurocysticercosis: clinical manifestations and problems in diagnosis.

Authors:  S Venkataraman; G P Vijayan
Journal:  J Assoc Physicians India       Date:  1979-06

6.  Cerebral cysticercosis.

Authors:  A K Percy; S E Byrd; G E Locke
Journal:  Pediatrics       Date:  1980-12       Impact factor: 7.124

7.  Neurological and related manifestations of cysticercosis.

Authors:  G P Vijayan; S Venkataraman; M L Suri; H N Seth; R S Hoon
Journal:  Trop Geogr Med       Date:  1977-09

8.  Serologic cross-reactions with sera from patients with echinococcosis and cysticercosis.

Authors:  P M Schantz; D Shanks; M Wilson
Journal:  Am J Trop Med Hyg       Date:  1980-07       Impact factor: 2.345

9.  Clinical aspects of CNS cysticercosis.

Authors:  J D Shanley; M C Jordan
Journal:  Arch Intern Med       Date:  1980-10

10.  Human cysticercosis: antigens, antibodies and non-responders.

Authors:  A Flisser; E Woodhouse; C Larralde
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

View more
  8 in total

1.  Anticysticercous antibodies in serum and cerebrospinal fluid in patients with cerebral cysticercosis.

Authors:  T Corona; D Pascoe; D González-Barranco; P Abad; L Landa; B Estañol
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-09       Impact factor: 10.154

2.  Immunodiagnosis of human neurocysticercosis by enzyme-linked immunosorbent assay.

Authors:  A Plancarte; B Espinoza; A Flisser
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

3.  Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru.

Authors:  H H Garcia; M Martinez; R Gilman; G Herrera; V C Tsang; J B Pilcher; F Diaz; M Verastegui; C Gallo; M Porras
Journal:  Lancet       Date:  1991-08-31       Impact factor: 79.321

4.  A prognostic classification of cerebral cysticercosis: therapeutic implications.

Authors:  B Estañol; T Corona; P Abad
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

5.  Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis.

Authors:  Silvia Rodriguez; Pierre Dorny; Victor C W Tsang; E Javier Pretell; Jef Brandt; Andres G Lescano; Armando E Gonzalez; Robert H Gilman; Hector H Garcia
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

6.  Characterization by enzyme-linked immunosorbent assay of the humoral immune response in patients with neurocysticercosis and its application in immunodiagnosis.

Authors:  B Espinoza; G Ruiz-Palacios; A Tovar; M A Sandoval; A Plancarte; A Flisser
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

Review 7.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 8.  Immunodiagnosis of neurocysticercosis: ways to focus on the challenge.

Authors:  M Esquivel-Velázquez; P Ostoa-Saloma; J Morales-Montor; R Hernández-Bello; C Larralde
Journal:  J Biomed Biotechnol       Date:  2011-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.